
    
      Adult subjects will be recruited with: new onset type 1 diabetes mellitus (T1DM), type 2
      diabetes mellitus (T2DM) as well as islet transplant candidates. Blood samples will be
      collected at defined intervals to determine beta-cell specific EV and determine the utility
      of this biomarker as a measure of beta-cell stress or injury.
    
  